NCT03960866View on ClinicalTrials.gov

Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

May 28, 2019

Primary Completion Date

September 11, 2019

Study Completion Date

September 11, 2019

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

Phentolamine Mesylate Ophthalmic Solution 1%

Topical Sterile Ophthalmic Solution

OTHER

Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)

Topical Sterile Ophthalmic Solution

Trial Locations (5)

14618

Rochester Ophthalmological Group, Rochester

30260

Clayton Eye Clinical Research, Morrow

44115

Abrams Eye Center, Cleveland

48105

University of Michigan Kellogg Eye Center, Ann Arbor

91345

North Valley Eye Medical Group, Mission Hills

Sponsors
All Listed Sponsors
lead

Ocuphire Pharma, Inc.

INDUSTRY

NCT03960866 - Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma | Biotech Hunter | Biotech Hunter